Maravai Lifesciences Holdings (MRVI) Net Margin (2020 - 2025)
Historic Net Margin for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to 108.23%.
- Maravai Lifesciences Holdings' Net Margin rose 1416100.0% to 108.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 111.11%, marking a year-over-year increase of 57900.0%. This contributed to the annual value of 100.17% for FY2024, which is 522800.0% down from last year.
- Latest data reveals that Maravai Lifesciences Holdings reported Net Margin of 108.23% as of Q3 2025, which was up 1416100.0% from 147.34% recorded in Q2 2025.
- Maravai Lifesciences Holdings' Net Margin's 5-year high stood at 64.57% during Q2 2022, with a 5-year trough of 249.84% in Q3 2024.
- In the last 5 years, Maravai Lifesciences Holdings' Net Margin had a median value of 17.33% in 2023 and averaged 26.27%.
- Per our database at Business Quant, Maravai Lifesciences Holdings' Net Margin crashed by -2272600bps in 2024 and then surged by 1416100bps in 2025.
- Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Net Margin stood at 55.64% in 2021, then decreased by -23bps to 42.71% in 2022, then crashed by -447bps to 148.34% in 2023, then surged by 45bps to 81.45% in 2024, then tumbled by -33bps to 108.23% in 2025.
- Its Net Margin was 108.23% in Q3 2025, compared to 147.34% in Q2 2025 and 112.81% in Q1 2025.